World-leading Singapore research institute, the Observational Pragmatic Research Institute (OPRI), is the largest contributor to the global understanding of inhalers for lung disease and was recently featured in a systematic review about the...
Read more
Professor David Price recently spoke about the management of asthma in different phenotypes at the Asian Pacific Society of Respirology’s Asthma Symposium 2019. While asthma hospitalization and mortality rates have been declining in past years, a...
Read more
A study by OPRI published in NPJ Primary Care Respiratory Medicine found a link between ICS therapy for patients with COPD and the onset of type 2 diabetes and osteoporosis.1 SINGAPORE – A study by OPRI published in NPJ Primary Care Respiratory...
Read more
A study by OPRI describing in details the GOLD group distribution in patients with COPD who started their initial treatment and those with established COPD has been recently published in the Journal EClinicalMedicine.1 The 2019 update of the...
Read more
Washington, 11th July 2019 – Professor David Price, head of The Observational & Pragmatic Research Institute (OPRI; Singapore) and Optimum Patient Care (OPC; Australia and UK), and Primary Care Respiratory Society Professor of Primary Care...
Read more
A study to assess the frequency of CRB65 scoring in patients diagnosed with community-acquired pneumonia (CAP) in primary care has been recently published in the Dove Press journal Pragmatic and Observational Research[1]. Community-acquired...
Read more
Allergic allergy has been increasing in Hong Kong given evolutionary and genetic or environmental factors. Omalizumab, or anti-IgE, is a monoclonal antibody approved for use in Hong Kong, primarily to treat severe persistent allergic asthma...
Read more
The PCRS Respiratory Conference is the UK’s leading respiratory conference. Its aim is to inspire delegates to discover new ways of working with patients and colleagues, helping them to respond positively to the challenges of primary and...
Read more
First-of-its-kind registry to exclusively focus on chronic obstructive pulmonary disease (COPD) treatment by primary care physicians   Registry will track 3,000 patients and first findings will be announced later in 2019 Ridgefield, Conn., May...
Read more
Drugs traditionally used to treat blood pressure and heart disease are to be given to lung disease patients to see if they can be beneficial, in a trial coordinated by the University of Aberdeen. Chronic obstructive pulmonary disease (COPD) is a...
Read more
A CRN supported Respiratory Disorders trial (TWICS), which investigated whether taking a low-dose theophylline tablets in addition to inhaled corticosteroids would reduce chronic obstructive pulmonary disease flare-ups was recently published by...
Read more
Singapore, 5th October 2018. Most people with asthma rely on inhaled asthma medication to control their symptoms. Inhaler devices are available as either dry powder inhaler (DPI) or pressurised metered dose inhaler (pMDI). Both devices require...
Read more